GBDR1 Polyclonal Antibody

Rabbit Anti-GBDR1 Polyclonal Antibody

Product Specifications

Background

Ubiquitin-associated domain-containing protein 1 is a non-catalytic subunit of the KPC complex that acts as E3 ubiquitin-protein ligase. Required for poly-ubiquitination and proteasome-mediated degradation of CDKN1B during G1 phase of the cell cycle. Diseases associated with UBAC1 include acute cystitis and bladder disease. Among its related pathways are Immune System and Antigen processing- Ubiquitination and Proteasome degradation.

CAS Number

9007-83-4

Product Name Alternative

UBAC1; GBDR1; KPC2; UBADC1; Ubiquitin-associated domain-containing protein 1; UBA domain-containing protein 1; E3 ubiquitin-protein ligase subunit KPC2; Glialblastoma cell differentiation-related protein 1; Kip1 ubiquitination-promoting com

Gene ID

10422

Accession Number

Q9BSL1

Reactivity

Human, Rat, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human GBDR1 at AA range: 60-140

Clonality

Polyclonal

Tag

Ubiquitin-associated domain-containing protein 1

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

45kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

GBDR1 Polyclonal Antibody detects endogenous levels of GBDR1 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:10000; IF 1:50-200